tirzepatide nejm In the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly in persons with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or severe fibrosis. Full trial results and Plain Language Summary Tirzepatide outperforms semaglutide in NEJM

Each session is about 30 minutes, and there is no downtime so that patients can continue their normal daily routines

Combining genetic insight with a detailed medication and bleeding history allows your provider to design a personalized GLP-1 protocol that minimizes injection complications

"Their brain is constantly telling their body that they don't have enough They don't have enough fuel

doi:10.1007/s00125-021-05391- Edelman SV, Argento NB, Pettus J, Hirsch IB

To have the same power to detect the same effect for subject treated with ALCAR 1.5 g/day 45 additional pairs are needed

There are different types of bariatric surgery, but all are designed to physically alter aspects of your digestive system to make it easier for you to manage your weight